Chlorosuccinimide → 3-Chloro-5-{5-[4-phenyl-5-(trifluoromethyl)-2-thienyl]-1,2,4-oxadiazol-3-yl}-1H-indole

HRID 423297ノート

反応式

HRID 423297 の反応式
[C:1]1([C:7]2[CH:8]=[C:9]([C:16]3[O:20][N:19]=[C:18]([C:21]4[CH:22]=[C:23]5[C:27](=[CH:28][CH:29]=4)[NH:26][CH:25]=[CH:24]5)[N:17]=3)[S:10][C:11]=2[C:12]([F:15])([F:14])[F:13])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.C1C(=O)N([Cl:37])C(=O)C1>C(Cl)Cl>[Cl:37][C:24]1[C:23]2[C:27](=[CH:28][CH:29]=[C:21]([C:18]3[N:17]=[C:16]([C:9]4[S:10][C:11]([C:12]([F:15])([F:14])[F:13])=[C:7]([C:1]5[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=5)[CH:8]=4)[O:20][N:19]=3)[CH:22]=2)[NH:26][CH:25]=1

参加物

4

実験手順

D2 (200 mg) and NCS (65 mg) were dissolved in DCM (5 ml) and stirred overnight at room temperature. The reaction mixture was then partitioned between DCM and H2O. The DCM solution was evaporated to dryness and purified on a Biotage silica cartridge, eluting with a 25-75% mixture of diethyl ether in hexane. This gave the title compound (36 mg) as a brown solid. A second batch of the title compound was also obtained from this purification (86 mg) as a brown solid. δH (CDCl3, 400 MHz): 7.28 (1H, m), 7.45-7.54 (6H, m), 7.93 (1H, s), 8.05 (1H, d), 8.28 (1H, br s), 8.49 (1H, s). MS (ES): C21H11ClF3N3OS requires 445; found 444 (M−H+).

後処理

  1. customThe reaction mixture was then partitioned between DCM and H2O
  2. customThe DCM solution was evaporated to dryness
  3. custompurified on a Biotage silica cartridge
  4. washeluting with a 25-75% mixture of diethyl ether in hexane

出典と根拠

ORDレコード
ord-41150b8ae4ab410f884a2e746a5d460b
出典データセット
uspto-grants-2012_01
特許番号
US08101775B2

反応ノート

読み込み中…